Randox would like to Congratulate Eileen Nixon on her Retirement
Randox would like to Congratulate Eileen Nixon on her Retirement
Randox would like to congratulate Eileen Nixon on her retirement!
Eileen has been a valuable member of Randox for 32 years beginning her career here in November 1990. She describes how remarkable the growth of Randox has been. From a smaller scale business back in 1990 to now the largest diagnostics company from the UK.
On Thursday morning, we celebrated Eileen’s achievements and fond memories during her time in our Manufacturing Division, within the Packing Team. The room was filled with Eileen’s colleagues, many of whom had worked with Eileen for well over 20 years. Eileen has been a great member of the Randox team and will be sorely missed.
We wish Eileen good health and every happiness for her retirement.
ABOUT RANDOX
NEWS
VACANCIES
OUR PEOPLE
Randox collaborate with Verv Technologies to Improve Health for All
Randox Laboratories, the largest diagnostics company from the UK, are proud to announce a $3.8m CAD seed round with Verv Technologies.
Randox Laboratories are the lead investor for Verv Technologies, who are focused on creating the first of its kind consumer-oriented, affordable, high-quality blood chemistry analyser with disposable tests for home use, that will help individuals measure a wide range of analytes (i.e., cholesterol, vitamin levels, hormones). With over 40 years of diagnostic experience, Randox Laboratories are focused on investment into technologies to improve health for all.
Dr. Peter Fitzgerald, Managing Director of Randox Laboratories shared, “Randox has a global lens on the development of new technologies. We have a shared vision and belief in Verv’s unique, highly differentiated microfluidics approach to creating scalable, high-quality, low-cost blood testing technology for healthcare consumers. We anticipate a great journey ahead, in partnership with Verv.
Jeff Sutton, Founder and President of Verv Technologies describes, “We are thrilled to have Randox as a major investor in Verv to help propel us to commercial readiness and the opportunity to work with the original Founder and Managing Director of Randox, Dr. Peter Fitzgerald, who will join Verv’s Board of Directors. We aim to create great value for health-conscious consumers.”
Randox and Verve share a commitment to transform testing on a global scale for the benefit of healthcare consumers.
ABOUT RANDOX
NEWS
VACANCIES
OUR PEOPLE
Randox response to the Public Accounts Committee (PAC) report, āGovernmentās contracts with Randox Laboratories Ltdā
27th July 2022: Randox response to the Public Accounts Committee (PAC) report, ‘Government’s contracts with Randox Laboratories Ltd’
A spokesperson for Randox said:
“The PAC report is deeply flawed and wrong in assumptions it makes and the conclusions it draws about Randox.
“As the UK’s largest diagnostic company, with four decades of experience, over 2,000 professional staff on hand at the start of the pandemic and more than £350m of prior investment in diagnostic and engineering innovation, Randox was uniquely situated to respond to the national need when COVID-19 emerged in early 2020.
“In supporting the UK’s urgent requirement for coronavirus testing Randox reacted with speed, efficiency and flexibility in delivering value. The company developed and built, in record time, the UK’s largest COVID-19 laboratories and testing services. It provided the Department of Health and Social Care with a PCR testing capacity at the time of greatest need, rising from 300 tests per day to 120,000 per day by January 2021.
“Altogether Randox processed over 25 million samples for UK’s National Testing Programme and in support of international travel for business and personal reasons. This played a crucial role in keeping vital elements of the UK economy functioning during lockdowns.
“In adapting to rapidly changing DHSC and Department of Transport requirements, Randox delivered unique value to the government, the national economy and to individuals.
“At no stage, either during its deliberations or in its preparation of this report, did the PAC make any contact whatsoever with Randox. Consequently many elements of its report relating to Randox are false, based as they are, on wrong and unchecked assumptions about the company. For that reason, they and any publications arising from them are the subject of a legal complaint.”
“The issues the report raises around internal DHSC record keeping are clearly a matter for DHSC”
For all media enquiries, please contact Ian Monk on ian@ianmonk.com or +44 7970 026072 / + 44 203 011 1933
Randox in the media
Latest News
FAQs
AACC 2022
We will be exhibiting at AACC Annual Scientific Meeting and Clinical Lab EXPO 2022!
Come visit us at The McCormick Place Convention Center in Chicago from 26th July-28th July 2022.
Visit booth #1419 where we will be discussing innovative diagnostic products and solutions, as well as showcasing our pioneering technologies!
Our Extensive Product Range
With 40 years of experience in the industry, we are experts in the field. Visit our website to find out more. Our Product Specialists Team will be available at booth #1419 to answer any questions, but why not plan ahead? Request a meeting with any of our Randox representatives and secure a time slot across the 5 day event.
Meet The Team
Click on the team member’s photo to request a meeting
James Crilly
QC Marketing Manager
Martin Conway
Marketing Manager
Dylan Sarrge
International Sales Executive
Shannon McKee
Business Development Analyst
Daniel Vance
Business Development Manager
Sarah Regan
Global Corporate Accounts Manager
Graeme McNeill
Global Business Manager
Rajneesh Mathur
VP Sales
John Naizer
National Sales Manager
Stefany Jainarine
Regional Sales Manager
Carter Tjornehoj
Junior Sales Executive
Zach Cable
International Sales Executive
Brianna Shaw
Junior Sales Executive
Alicia Grattan
Business Development Executive
Michael Townsend
Business Development Manager
Maeve Loane
Supply Chain Lead – Strategic
Gary Robinson
Senior Buyer
Pankaj Sinha
VP Sales America
Caleb Johnson
Junior Sales Executive
Jake Heckenberg
Sales Executive
Louise Lynn
Head of Technical Services
Cheryl O'Hagan
Technical Support Team Leader
Ray Cameron
Head of Service Engineering
Feargal Barry
Team Lead – Customer Service Engineer
Emma Bateman
Business Development Manager
Kim Dickson
Events Manager
Randox to deliver Ā£10m investment for major UK research project
Diagnostics and personalised health company Randox to deliver £10m investment for major UK research project Our Future Health
Randox, the Northern Ireland-based diagnostics and personalised health company, has today been announced as one of four new industry partners in the Our Future Health (OFH) programme, which will be the UK’s largest ever health research programme.
Randox will deliver a £10m investment in the programme, which will discover and develop new methods of prevention, early detection and treatment of diseases and health conditions.
The company is one of four new partners who will deliver a total of £40m to OFH. They join 10 additional life sciences companies that were previously announced as funding partners in January 2022. As well as its £10m investment, Randox will contribute its world-leading expertise to the programme. Its network of 20 High Street clinics, including those in Holywood and Crumlin, will also be available if required to test volunteers from across the UK taking part in the OFH project. The project aims to monitor the long-term health of 5 million volunteers in the coming years, starting this autumn.
Andrew Roddam, Chief Executive of OFH, said: “We are delighted to be announcing a further four industry partners for OFH, who together will provide an additional £40m to further our objective to develop new ways to prevent, detect and treatments enabling people to live healthier lives for longer. We welcome Randox as one of these partners, knowing their long-term commitment to diagnostics, and look forward to working with them in the months and years ahead.”
OFH has also joined with 16 health research charities, who have endorsed the pilot phase of the programme and are providing valuable support and experience.
Volunteers will be asked to complete an online health questionnaire, give their informed consent to link information from their healthcare records to OFH and donate a small blood sample.
Volunteers are also being asked to give their permission for OFH to contact them in the future to give them the opportunity to take part in follow-on research and to provide personal feedback about their health, should they wish to receive it.
Researchers from across the life sciences community, including academia, industry and the NHS, will be able to apply to study OFH resources as part of their crucial research to accelerate the discovery and development of innovative diagnostics and treatments.
Volunteers’ data will be de-identified and held in ‘trusted research environments’ that meet strict security criteria and an access board, which will include independent experts and members of the public, to ensure OFH resources are only used for health research in the public interest.
Randox Managing Director, Dr Peter FitzGerald said:
“Randox has been engaged from the very outset and is now excited to formally support this world-leading research project, both as a funding member and with our considerable expertise.
“With over 40 years of diagnostic experience, and extensive research capabilities, Randox knows that a personalised approach to the early detection and prevention of disease is not only critical to saving and extending life, but also to improving the quality of our lives. This project will further those critical goals. The ability for participants to receive feedback on their health from the project, and to engage with future research, also promotes Randox’s objective of greater individual ownership of health.
“Randox is committed to providing accessible and affordable testing to drive significant health improvements through the early detection and prevention of disease. ‘Our Future Health’ is perfectly aligned with that vision.”
Members of the public who are interested in taking part in Our Future Health later this year can register for news and updates at www.ourfuturehealth.org.uk
For more information contact:
Mia Taylor
mia.taylor@woburnpartners.com
+44 (0) 7891525749
James Robinson
james.robinson@woburnpartners.com
Want to know more?
Contact us
Related Pages
ABOUT RANDOX
NEWS
VACANCIES
OUR PEOPLE
EUROMEDLAB 2022
We are attending EUROMEDLAB 2022!
Come visit us in Munich from 10th-14th April at EuroMedlab 2022!
We will be at stand 7 where you can discover how we are currently revolutionising healthcare with our innovative products!
Our Extensive Product Range
With 40 years of experience in the industry, we are experts in the field. Visit our website to find out more. Our Product Specialists Team will be available at Hall 3, Stand 218 to answer any questions, but why not plan ahead? Request a meeting with any of our Randox representatives and secure a time slot across the 3 day event.
Meet The Team
Our Product Specialists Team will be available to answer any questions, but why not plan ahead? Request a meeting by clicking on the team member’s photo to secure a dedicated time slot to talk with a Randox representative.
Dipesh Varu
Regional Sales Manager, Midlands and East Anglia
Dipesh has worked for Randox Laboratories for the last 7 years. Very experienced when it comes to our Acusera range of products.
Ben Crawford
Molecular Product Specialist, Team Leader
Ben has been working at Randox for 5 years and during his time he has become an expert in the field of molecular diagnostics. Stop by our booth and discuss Qnostics, QCMD, Vivalytic, Discovery and more with Ben.
Jana Kohutova
Sales Manager Slovakia
After study of General Biology at University of Matej Bel (Slovakia) Jana started working at RANDOX in the Sales Department Slovakia in July 2005. Continual business development with best possible effectiveness and profitability for company is my long-term key focus in RANDOX Slovakia. Sales projects contribute of all RANDOX product range including biochip array technology, molecular arrays.
Remy Patton
Business Development Manager, Poland
Remy is the Business Development Manager for Poland and the Balkans (Croatia, Serbia, Macedonia, Bosnia), actively promoting the clinical product portfolio. Graduating from Edinburgh Napier University with a Biomedical Science degree and have been working in Randox sales department since September 2019.
Bryony Boyd
European Sales Manager
Bryony Boyd is one of the Randox European Sales Managers for the clinical product portfolio. A biomedical science graduate from University of Ulster, Bryony has been actively promoting the Randox clinical portfolio to the Baltics, Austria, Slovenia, Greece, Cyprus and Switzerland. Her main focus is IQC, EQA, Rx Series, Vivalytic and Reagents.
Heidi Dowswell
Product Specialist, European Region
Heidi is the Randox Product Specialist for the European region. A Zoology graduate from Queen’s University Belfast, Heidi has actively been promoting the Randox clinical portfolio to the Nordics, BeNeLux, Albania, Moldova and Romania. Her main focus is IQC, EQA, Rx Series, Reagents and Vivalytic. Heidi has been working in Randox since 2019, firstly as a Technical Support Scientist and now as a Product Specialist in the sales department.
Esin Yildiz
Business Development Manager
Esin is a Business Development Manager For Balkan Countries, Germany, France, Turkey and Portugal. Esin focuses on Food and Tox.
Diana Adashankar
Business Development Manager, France
After a Master’s degree in BioEngineering and BioTechnologies in the Healthcare Industry, Diana has gained experience as Marketing and Sales Executive for more than 7 years in the medical & pharmaceutical field.
Alexander Genin
National Sales Manager , France
Alexander followed an International Business Administration bachelor and specialised in innovation management Master degree at the Rotterdam School of Management in the Netherlands. He moved into his first role within Randox as Sales Representative. After 2 successful years, he moved to a Sales Team Leader position and then to the National Sales Manager position. He is 100% dedicated to improving healthcare in France and in accompanying Randox in doing so worldwide.
Luciano Colucci
International Sales Manager, South East Italy
Luciano has been working in Randox since March 2010 as sales consultant for south-east Italy. Dedicated to develop and follow customer for centre-south Italy. As Sales Manager, he is focused on QA, Reagents, Toxicology and molecular product. Luciano also has a private interest to organic farming dedicated to improving human nutrition.
Alessandro Vallone
International Sales Manager, Italy
Alessandro is an International Sales Manager with years of experience in drug testing monitoring and creating tailor-made solutions for laboratories, hospitals and government facilities.
Rachel Foresyth
Molecular Product Specialist
Rachel Forsythe began her career with Randox working as a Biochip Analyst and Extraction Scientist in the COVID Laboratories during the pandemic. Rachel is now working as a Molecular Product Specialist on a global scale. She also specialises in the Randox Point of Care analyser, the VeraSTAT for both clinical and veterinary as she studied Zoology in University.
Ray Cameron
Head of Service Engineering
Ray has been in Randox since 2013 and has extensive experience from roles in sales support, technical training and management of the global service group.
James Crilly
Marketing Manager
Since joining the company in 2015, James has been part of the Quality Control Marketing team, promoting our range of Acusera controls, RIQAS EQA programmes and Acusera 247 data management software across the globe. He also has experience in the promotion and marketing of Qnostics and QCMD. More recently he has moved to a corporate role and now part of the team responsible for managing our advertising, events, marketing automations, sponsorships and more.
Martin Conway
Marketing Manager
Martin is one of the clinical marketing team managers, promoting our diverse range of analysers including Chemistry, Immunoassay, Molecular and Point of Care. He also has experience in collaborative promotion and corporations with our business partners and distribution network along with experience in advertising, events, sponsorships and more.
Global Leaders combine to provide pre-race COVID testing of UAE Team Emirates
Monday 28th March 2022: Global Leaders combine to provide pre-race COVID testing of UAE Team Emirates
Randox, a world leader in Health Diagnostics has been announced as the Official Supplier of UAE Team Emirates. The two-time winners of cycling’s most prestigious prize, the Tour de France.
The agreement will see UAE Team Emirates utilise the Vivalytic, a point of care platform brought to the market by Randox Laboratories and Bosch Healthcare Solutions to test riders and the wider support staff for COVID prior to upcoming races and tours.
The Bosch Vivalytic brings innovation to the Molecular Diagnostic testing market. A fully automated, sample to point of care diagnostic machine with the full molecular workflow consolidated into one small benchtop platform.
The ethos of improving healthcare which drove Randox Managing Director Dr Peter Fitzgerald to start the company in the 1980s is clearly reciprocated by their new partners. From their initiation into the top tier of professional cycling in 2017, UAE Team Emirates have had the aim of representing an entire nation, the UAE, and promoting a healthy lifestyle through cycling.
Team UAE Emirates are the newest addition to Randox’s growing portfolio of elite sporting sponsorships, which includes; GB Olympic and Paralympic teams, Sheffield United Football Club, Olimpia Milano and the Aintree Randox Grand National. The first endeavour into the United Arab Emirates sporting industry comes as no surprise as Randox have been providing UAE Hospitals, Universities and Veterinary centres with their broad range of products and services, offering a comprehensive insight into patient diagnosis to facilitate more effective disease management and treatment for a number of years.
Giulio Saule, Randox International Sales Manager stated:
“For a Global Company such as Randox it is an honour to be supplier of COVID tests to UAE Team Emirates, a team that in both 2020 and 2021 won the Tour de France and ended in the top 5 of the UCI Teams Ranking. The effort of the team in talents looks exactly the same as Randox effort in bringing innovative technologies on the market. This cooperation then brings Randox in one of the elite sports where surely there may be different horizons than COVID.”
Andrea Agostini, chief operating officer UAE Team Emirates stated:
We have paid a lot of attention against this virus since the beginning. For us the health of our members is a priority and to have the possibility to test them always, autonomously, during the cycling season is a big advantage.
About Team UAE
UAE Team Emirates entered the highest level of professional cycling, the World Tour, in early 2017. The team has the aim of representing an entire nation, the UAE, and promoting a healthy lifestyle linked to the use of the bicycle.
Season after season, the Emirati team has attracted a growing number of world-class riders and quality sponsors, taking them to new heights and successes in the biggest races in the world. The culmination of this growth and success has come with the victories of Tadej Pogacar in the Tour de France in 2020 and 2021.
For further information please contact James Crilly; james.crilly@randox.com / 028 9442 2413
Want to know more?
Contact us or visit UAE Team Emirates.
Related Pages
ABOUT RANDOX
NEWS
VACANCIES
OUR PEOPLE
IBMS Congress 2022
We are attending IBMS Congress!
Come visit us at The National Convention Centre (ICC) from 14th-17th March 2022.
We will be in Hall 3, Stand 218 where you can discover how we are currently revolutionising healthcare with our innovative products!
Our Extensive Product Range
With 40 years of experience in the industry, we are experts in the field. Visit our website to find out more. Our Product Specialists Team will be available at Hall 3, Stand 218 to answer any questions, but why not plan ahead? Request a meeting with any of our Randox representatives and secure a time slot across the 3 day event.
Meet The Team
Click on the team member’s photo to request a meeting
Barry Maguire
Clinical Sales Manager, South England
Barry joined Randox 5 years ago and he currently leads our team in the South of England. Barry also manages some customer accounts directly in North England and has a keen interest in our IQC software package, Acusera 24.7.
Dipesh Varu
Regional Sales Manager, Midlands and East Anglia
Dipesh has worked for Randox Laboratories for the last 7 years. Very experienced when it comes to our Acusera range of products.
Ben Crawford
Molecular Product Specialist, Team Leader
Ben has been working at Randox for 5 years and during his time he has become an expert in the field of molecular diagnostics. Stop by our booth and discuss Qnostics, QCMD, Vivalytic, Discovery and more with Ben.
Veena Vara
Sales Executive, North West England
Veena started working for Randox within the clinical team 4 years ago after completing BSc and MSc in Biomedical Science.
Jenna Ireland
Sales Executive, South-West England
Jenna completed her University Placement with Randox whilst working within the Global sales team. She has currently been working for Randox for 3.5 years
Tome Cardoso
Sales Executive, London
Tome is a Sales Executive using his extensive experience in the lab to help our customers find the best solutions for their testing needs by using innovative Randox products. Tome has experience as a Biomedical Scientist at a Senior level having worked in several hospitals across London for the past 7 years.
Conor Gallagher
Sales Manager, Ireland
Conor has been working for Randox for over 7 years and managing the Irish market for the majority of that time. Conor has taken a keen interest in a new range of POC EQA products that Randox has launched. Please feel free to call by the stand to discuss these products in more detail
Dermot Devlin
Business Development Executive, Scotland & Wales
Dermot has spent 2 years travelling extensively in Sub Saharan Africa and Asia promoting the importance of quality within the laboratory, Dermot is now focusing his time on developing the Randox ethos in both Scotland and Wales.
Chuckwuma Georgewill Manjor
Sales Executive, Ireland
Chukwuma has been with Randox for over a year now and specialises in clinical sales within our Irish sales team in particular to Point of Care, Research and University institutions.
Adam Wilson
Molecular Product Specialist, Ireland
Adam is the newest addition to the Irish Team. Adam’s focus within the team is the molecular product range. If you have any queries regarding any of the molecular products please feel free to call by and he will be happy to discuss these with you.
Ashleigh Rudd
Sales Executive, South Central England
Ashleigh recently started working for Randox having previously been a Biomedical Scientist in Microbiology, Haematology and Blood Transfusion.
Response to release of specified minutes, notes and correspondence relating to Government contracts awarded to Randox
4th February 2022: Response to release of specified minutes, notes and correspondence relating to Government contracts awarded to Randox
A spokesperson for Randox said:
“It is clear from these papers that Randox contracts were awarded in full compliance with government procedures and protocols in place at a time of the emerging pandemic.
“The awarding of the contracts reflected Randox’s extensive diagnostics capabilities within the UK and 40 years of experience in that field. As Secretary of State, Sajid Javid says in his statement, the service Randox provided was integral to the rapid building, from scratch, of the largest ever testing industry in UK history.
“Randox’s laboratories expanded rapidly in order to operate at scale and were the first laboratory to report over 100,000 PCR results in a day. It is clear from these papers that the company has delivered a vital and core part of the UK’s testing capacity.
“Randox remains proud of its performance and delivery of Covid 19 testing throughout the pandemic. To date Randox has reported almost 24 million PCR results and has played a key role in both keeping people safe and sustaining vital national infrastructure.
“Unlike other laboratories Randox was able from the outset to provide whole-system capabilities to deliver the tests. Both the World Health Organisation and the UK government agreed this capability was crucial to combating the pandemic.”
For all media enquiries, please contact Ian Monk on ian@ianmonk.com or +44 7970 026072 / + 44 203 011 1933
Randox in the media
Latest News
FAQs
2 years on…since the development of the Randox COVID-19 Biochip
Wednesday 02 February 2022: 2 years since the Randox COVID-19 Biochip
February 2022 marks 2 years since the development of the Randox COVID-19 Biochip.
In February 2020, based on almost four decades of experience in diagnostic R&D, including the development of a CE marked panel of tests for fifteen respiratory viruses, as well as tests for SARS and MERS, Randox recognised the threat from COVID-19 and quickly developed a test to accurately identify the virus.
And a lot has happened since then…
Randox’s capability was recognised by the UK government and since March 2020 Randox has been contracted to provide COVID-19 testing support to the UK’s Pillar 2 National Testing Programme. The company immediately pivoted to move from a 9-5 business to a 24|7 operation.
Through the enormous effort and commitment of its staff Randox has (at the time of writing) processed more than 23 million gold-standard PCR tests for the National Testing Programme and for international travel – providing a reliable service to enable COVID-safe travel which facilitates personal, family and business engagements and activities during the pandemic.
Demonstrating its commitment to helping people live their lives as easily and normally as possible, and to enhance accessibility to travel testing, the company partnered with major airlines including British Airways, Easyjet, Ryanair, Wizz Air, Cathay Pacific, and Jet2, travel providers such as TUI, and travel agents including the DNATA Travel Group, to provide discounted travel tests. By investing in testing capacity, logistic capabilities, and the introduction of a dedicated Customer Support team, Randox could make greater efficiencies that allowed it to reduce the price of PCR testing and become the most competitive service in the UK and Ireland.
During the 2020 Olympic Games, Randox got Team GB safely to the starting line in Tokyo by providing the Olympians with its premium COVID-19 testing, a service which it also provided for the ParalympicsGB athletes. A number of other sporting organisations opted to make Randox their COVID-19 testing provider of choice for their players and supporting staff, including the Irish Football Association, the US Men’s National Soccer Team, and Premiership Rugby, to ensure a COVID-safe training environment. Using Randox diagnostic technologies, companies like Norbrook Laboratories and Northern Ireland Screen were able to implement a staff screening programme that demonstrated a high standard of duty of care to their employees.
As and when required, Randox rapidly established new customer-focused services catered to the needs of the ever-changing travel testing guidelines. In May 2021, for example, Randox launched a ‘test to return’ service for UK holidaymakers returning home from Portugal and requiring predeparture tests before their return flight. In a first for the industry, passengers were able to take their PCR kit to Portugal and return their sample to one of Randox’s partner labs in the Algarve, before Randox flew the samples back to its labs in the UK for testing.
The company also provides tests for COVID-19 antibodies, as well as lateral flow testing services, where such tests satisfy international travel requirements, and has developed an innovative phone app to securely process and verify customer identification and results in just 15 minutes.
Randox has amongst the very largest laboratories in Europe and since the start of the pandemic has built, equipped and staffed 80,000 sq ft of PCR testing facilities, in Northern Ireland, Manchester and Greater London, and 50,000 sq ft of supporting logistic and engineering space. Randox has opened a number of mobile testing labs as well as almost 30 travel clinics, for COVID-19 testing appointments and over-the-counter home testing kit purchases. Walk-through and drive-through test centres have opened across a number of key airport locations, some in partnership with renowned travel services provider Collinson.
Randox is the only testing provider in the UK within this reporting period to have reported over 100,000 PCR results in a single day. Turnaround times for test results are rigorously monitored to meet the needs of both Government and private customers.
The company has more than doubled its workforce since 2020 and has developed a robust and comprehensive nationwide logistics network for the timely distribution and return of sample collection kits and samples. In collaboration with reputable partners including Morrisons supermarkets, Wells Pharmacies, Roadchef and PayPoint, Randox has established almost 200 PCR sample dropboxes and over 1500 click and collect sites, with the aim of improving customer accessibility and simplifying the process of COVID-19 testing requirements.
By responding rapidly, dynamically and cost-effectively to an ever-changing environment, with updates to travel testing requirements often being made at short notice, Randox has played an important role in managing the effects of the pandemic in both the UK and Ireland, facilitating safe social and economic activity, including international travel.
For further information on Covid testing services please contact the Randox Covid Customer Support team on 028 9434 3005.
For press enquiries please contact Amy Millar in the Randox PR team: randoxpr@randox.com
Want to know more?
Contact us or visit Randox Health.